# Glutathione in Mild Cognitive Impairment

> **NCT03493178** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Baylor College of Medicine** · enrollment: 60 (estimated)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **DIETARY_SUPPLEMENT:** Glycine
- **DIETARY_SUPPLEMENT:** N-acetylcysteine (NAC)
- **DIETARY_SUPPLEMENT:** Alanine

## Key facts

- **NCT ID:** NCT03493178
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-04-19
- **Primary completion:** 2025-05-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03493178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03493178, "Glutathione in Mild Cognitive Impairment". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03493178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*